Zhang, Min
Bzura, Aleksandra
Baitei, Essa Y.
Zhou, Zisen https://orcid.org/0000-0001-6122-5586
Spicer, Jake B. https://orcid.org/0000-0003-2842-7412
Poile, Charlotte
Rogel, Jan
Branson, Amy
King, Amy
Barber, Shaun
Kamata, Tamihiro https://orcid.org/0000-0002-2032-9300
Dzialo, Joanna https://orcid.org/0000-0001-6083-7687
Harber, James
Greystoke, Alastair https://orcid.org/0000-0001-9168-0387
Nusrat, Nada
Faulkner, Daniel https://orcid.org/0000-0003-3438-7330
Sun, Qianqian
Nolan, Luke
Hahne, Jens C.
Scotland, Molly
Walter, Harriet https://orcid.org/0000-0003-2618-711X
Darlison, Liz
Morgan, Bruno
Bajaj, Amrita
Brookes, Cassandra
Hollox, Edward J. https://orcid.org/0000-0002-0115-2298
Lubawska, Dominika
Jama, Maymun
Griffiths, Gareth
Nakas, Apostolos
Kutywayo, Kudzayi
Luo, Jin-Li
Klampatsa, Astero https://orcid.org/0000-0003-0572-502X
Cooper, Andrea https://orcid.org/0000-0001-6050-3863
Halder, Koirobi
Wells-Jordan, Peter
Zhou, Huiyu
Dudbridge, Frank https://orcid.org/0000-0002-8817-8908
Thomas, Anne
Richards, Catherine Jane
Pritchard, Catrin
Yang, Hongji https://orcid.org/0000-0001-6561-3631
Barer, Michael
Fennell, Dean A. https://orcid.org/0000-0001-7373-1312
Funding for this research was provided by:
Cancer Research UK (C10604/A25151)
Asthma + Lung UK VPDCF17-17 Victor Dahdaleh Foundation
Article History
Received: 4 October 2023
Accepted: 18 June 2024
First Online: 21 August 2024
Competing interests
: D.A.F. reports grants from Aldeyra, Astex Therapeutics, Bayer, BMS and Boehringer Ingelheim, Owkin; non-financial support from BerGenBio, Clovis, Eli Lilly, MSD, Roche, and Tesaro GSK; personal fees from Aldeyra, Cambridge Clinical Laboratories, Ikena, Opna Bio, Owkin, RS Oncology, Roche, MSD, during the conduct of the study. All other authors declare no competing interests.